Skip to main content
logo
Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
7.08
+0.02 (0.28%)
Jun 18, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.24.95.174.535.514.47
Revenue Growth (YoY)
10.70%-5.22%14.24%-17.77%23.11%443.62%
Gross Profit
5.24.95.174.535.514.47
Selling, General & Admin
12.6212.4113.1811.657.448.28
Research & Development
24.423.7234.4333.7735.0220.02
Other Operating Expenses
-5.41----
Total Operating Expenses
37.0241.5447.6145.4242.4528.3
Operating Income
-37.23-36.63-42.44-40.89-36.95-23.82
Interest Income
0.390.390.70.180.030.01
Interest Expense
-18.55-16.59-10.74-2.63--0.06
Other Non-Operating Income (Expense)
-227.23-120.9633.57-25.71-0.73
Total Non-Operating Income (Expense)
-245.39-137.1723.52-28.160.030.67
Pretax Income
-266.32-173.8-18.92-69.05-36.92-23.16
Net Income
-282.61-173.8-18.92-69.05-36.92-23.16
Net Income to Common
-266.32-173.8-18.92-69.05-36.92-23.16
Shares Outstanding (Basic)
363636363424
Shares Outstanding (Diluted)
363636363424
Shares Change (YoY)
-31.78%0.22%0.24%5.20%42.27%46.84%
EPS (Basic)
-7.77-4.80-0.52-1.91-1.08-0.96
EPS (Diluted)
-7.77-4.80-0.52-1.91-1.08-0.96
Free Cash Flow
-24.47-26.31-39.43-55.57-34.69-24.88
Free Cash Flow Per Share
-0.67-0.73-1.09-1.54-1.01-1.03
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-715.65%-747.02%-820.18%-902.85%-670.77%-532.45%
Profit Margin
-5432.80%-3544.03%-365.60%-1524.51%-670.24%-517.55%
FCF Margin
-470.42%-536.40%-762.08%-1226.92%-629.85%-556.08%
EBITDA
-35.62-35.1-41.11-39.92-36.05-22.65
EBITDA Margin
-684.68%-715.80%-794.57%-881.39%-654.58%-506.32%
EBIT
-37.23-36.63-42.44-40.89-36.95-23.82
EBIT Margin
-715.65%-747.02%-820.18%-902.85%-670.77%-532.45%
SEC Filings: 10-K · 10-Q